Erratum: Increased mitochondrial oxidative phosphorylation in the liver is associated with obesity and insulin resistance (Obesity 19 (917-924) DOI: 10.1038/oby.2010.214);Increased mitochondrial oxidative phosphorylation in the liver is associated with obesity and insulin resistance

Obesity

Volumn 19, Issue 5, 2011, Pages 917-924

  Buchner, David A ^a   Yazbek, Soha N ^a   Solinas, Paola ^a   Burrage, Lindsay C ^a,b   Morgan, Michael G ^a   Hoppel, Charles L ^a   Nadeau, Joseph H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANATOMICAL VARIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENIC STRAIN; CONTROLLED STUDY; DIETARY INTAKE; ELECTRON TRANSPORT; ENDOCYTOSIS; GENE EXPRESSION PROFILING; GENETIC SUSCEPTIBILITY; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; LIVER; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; PHENOTYPE;

MUS;

EID: 79955473343     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.183     Document Type: Erratum

References (33)

1. Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
2. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006;119:S10-S16.
3. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:193-205. (Pubitemid 351301824)
4. Turner N, Heilbronn LK. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 2008;19:324-330.
5. Koves TR, Ussher JR, Noland RC et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56.
6. Pospisilik JA, Knauf C, Joza N et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 2007;131:476-491. (Pubitemid 350017761)
7. Liu J, Shen W, Zhao B et al. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients. Adv Drug Deliv Rev 2009;61: 1343-1352.
8. Buechler C, Schäffler A. Does global gene expression analysis in type 2 diabetes provide an opportunity to identify highly promising drug targets? Endocr Metab Immune Disord Drug Targets 2007;7:250-258.
9. Buchner DA, Burrage LC, Hill AE et al. Resistance to diet-induced obesity in mice with a single substituted chromosome. Physiol Genomics 2008;35:116-122.
10. Hsiao A, Ideker T, Olefsky JM, Subramaniam S. VAMPIRE microarray suite: a web-based platform for the interpretation of gene expression data. Nucleic Acids Res 2005;33:W627-W632. (Pubitemid 44529998)
11. Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545-15550. (Pubitemid 41528093)
12. Hoppel C, DiMarco J P, Tandler B. Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J Biol Chem 1979;254:4164-4170. (Pubitemid 9178641)
13. Hedbacker K, Birsoy K, Wysocki RW et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 2010;11:11-22.
14. Wheatcroft SB, Kearney M T, Shah AM et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 2007;56:285-294.
15. Almind K, Manieri M, Sivitz WI, Cinti S, Kahn CR. Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc Natl Acad Sci USA 2007;104: 2366-2371. (Pubitemid 46391403)
16. Li X, Monks B, Ge Q, Birnbaum MJ. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription co-activator. Nature 2007;447:1012-1016. (Pubitemid 46975750)
17. Newlands S, Levitt LK, Robinson CS et al. Transcription occurs in pulses in muscle fibers. Genes Dev 1998;12:2748-2758. (Pubitemid 28420654)
18. Kanehisa M, Araki M, Goto S et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008;36:D480-D484. (Pubitemid 351149770)
19. Ceresa B P, Kao AW, Santeler SR, Pessin JE. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Mol Cell Biol 1998;18:3862-3870. (Pubitemid 28287909)
20. Mootha VK, Lindgren CM, Eriksson KF et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-273. (Pubitemid 36792858)
21. Abdul-Ghani MA, DeFronzo RA. Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Curr Diab Rep 2008;8:173-178.
22. Misu H, Takamura T, Matsuzawa N et al. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 2007;50:268-277.
23. Takamura T, Misu H, Matsuzawa-Nagata N et al. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients. Obesity (Silver Spring) 2008;16:2601-2609.
24. Finck BN, Kelly D P. PGC-1 co-activators: Inducible regulators of energy metabolism in health and disease. J Clin Invest 2006;116:615-622. (Pubitemid 43326866)
25. Yoon JC, Puigserver P, Chen G et al. Control of hepatic gluconeogenesis through the transcriptional co-activator PGC-1. Nature 2001;413:131-138. (Pubitemid 32867868)
26. Samuel VT, Beddow SA, Iwasaki T et al. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. Proc Natl Acad Sci USA 2009;106:12121-12126.
27. Finck BN, Gropler MC, Chen Z et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARα regulatory pathway. Cell Metab 2006;4:199-210. (Pubitemid 44283957)
28. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem 2009;78:857-902.
29. Krishnan KS, Rikhy R, Rao S et al. Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron 2001;30:197-210. (Pubitemid 32441687)
30. Antonescu CN, Díaz M, Femia G, Planas J V, Klip A. Clathrin-dependent and independent endocytosis of glucose transporter 4 (GLUT4) in myoblasts: regulation by mitochondrial uncoupling. Traffic 2008;9:1173-1190. (Pubitemid 351916891)
31. Kao AW, Ceresa B P, Santeler SR, Pessin JE. Expression of a dominant interfering dynamin mutant in 3T3L1 adipocytes inhibits GLUT4 endocytosis without affecting insulin signaling. J Biol Chem 1998;273:25450-25457. (Pubitemid 28443314)
32. Shinyama H, Masuzaki H, Fang H, Flier JS. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 2003;144:1301-1314. (Pubitemid 36428472)
33. Galli S, Jahn O, Hitt R et al. A new paradigm for MAPK: structural interactions of hERK1 with mitochondria in HeLa cells. PLoS ONE 2009;4:e7541.